Skip to content

Understanding the types of COPD disease and how they affect the health :- A study based on past medical records in a hospital of South India

Proportion of chronic obstructive pulmonary disease phenotypes and its association with clinical outcomes among hospitalized chronic obstructive pulmonary disease patients in South India - A Retrospective Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/089233
Enrollment
174
Registered
2025-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J440- Chronic obstructive pulmonary disease with acute lower respiratory infection

Interventions

Intervention1: Nil: Nil

Sponsors

Ashwitha G Shanbhag
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients of age more than 18 years with a confirmed diagnosis of COPD

Exclusion criteria

Exclusion criteria: patients with incomplete medical records, patients with other co-existing respiratory diseases along with COPD, patients who have been diagnosed or treated very recently and do not have sufficient follow-up data to track the progression of the disease

Design outcomes

Primary

MeasureTime frame
Proportion of each clinical COPD phenotype Timepoint: Baseline

Secondary

MeasureTime frame
Distribution of different phenotypes across age, sex, & smoking history Frequency of hospitalization, requirement of ICU/ High dependency unit admission, requirement of NIV/ IMV, length of stay (hospital/ ICU), mortality Prevalence of comorbidities & hospitalization rates across different phenotypes Timepoint: At discharge

Countries

India

Contacts

Public ContactAshwitha G Shanbhag

Manipal College of Health Professions, MAHE, Manipal

pratibha.todur@manipal.edu8095103671

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026